See more : Ligua Inc. (7090.T) Income Statement Analysis – Financial Results
Complete financial analysis of National Health Investors, Inc. (NHI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National Health Investors, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- Dragoneer Growth Opportunities Corp. III (DGNU) Income Statement Analysis – Financial Results
- loanDepot, Inc. (LDI) Income Statement Analysis – Financial Results
- PT Adira Dinamika Multi Finance Tbk (ADMF.JK) Income Statement Analysis – Financial Results
- Corazon Mining Ltd (CRZNF) Income Statement Analysis – Financial Results
- CapitaLand Investment Limited (9CI.SI) Income Statement Analysis – Financial Results
National Health Investors, Inc. (NHI)
About National Health Investors, Inc.
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 319.84M | 278.19M | 298.72M | 332.81M | 318.08M | 294.61M | 278.66M | 248.50M | 228.99M | 177.51M | 117.83M | 96.95M | 82.70M | 78.40M | 64.22M | 63.01M | 62.31M | 150.72M | 157.38M | 155.56M | 162.49M | 171.78M | 139.17M | 147.51M | 131.16M | 102.29M | 110.18M | 99.43M | 87.90M | 71.40M | 49.50M | 39.40M | 7.90M |
| Cost of Revenue | 11.51M | 9.79M | 11.64M | 9.65M | 5.80M | 1.17M | 960.00K | 1.01M | 985.00K | 620.00K | 616.00K | 771.00K | 0.00 | 2.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 308.32M | 268.41M | 287.08M | 323.16M | 312.28M | 293.45M | 277.70M | 247.49M | 228.00M | 176.89M | 117.21M | 96.18M | 82.70M | 76.39M | 64.22M | 63.01M | 62.31M | 150.72M | 157.38M | 155.56M | 162.49M | 171.78M | 139.17M | 147.51M | 131.16M | 102.29M | 110.18M | 99.43M | 87.90M | 71.40M | 49.50M | 39.40M | 7.90M |
| Gross Profit Ratio | 96.40% | 96.48% | 96.10% | 97.10% | 98.18% | 99.60% | 99.66% | 99.59% | 99.57% | 99.65% | 99.48% | 99.20% | 100.00% | 97.44% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.23 | 0.38 | 0.57 | 0.50 | 0.52 | 0.58 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.72M | 25.32M | 19.34M | 14.56M | 13.91M | 12.86M | 12.71M | 10.20M | 10.98M | 9.32M | 10.04M | 8.57M | 8.03M | 8.85M | 7.21M | 5.18M | 5.66M | 5.34M | 4.31M | 3.49M | 3.14M | 2.43M | 3.30M | 3.46M | 3.28M | 3.89M | 3.70M | 3.69M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 100.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 19.82M | 25.32M | 19.34M | 14.56M | 13.91M | 12.86M | 12.71M | 10.20M | 10.98M | 9.32M | 10.04M | 8.57M | 8.03M | 8.85M | 7.21M | 5.18M | 5.66M | 5.34M | 4.31M | 3.49M | 3.14M | 2.43M | 3.30M | 3.46M | 3.28M | 3.89M | 3.70M | 3.69M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 109.71M | 99.92M | 134.35M | 84.68M | 78.37M | 71.35M | 67.17M | 1.66M | 53.16M | 38.08M | 3.31M | 4.85M | 12.81M | 11.05M | 7.37M | 8.55M | 2.36M | 95.15M | 116.67M | 96.24M | 101.89M | 127.25M | 115.83M | 81.79M | 99.86M | 47.87M | 53.31M | 49.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 129.53M | 125.24M | 153.69M | 99.23M | 92.27M | 85.37M | 80.84M | 70.77M | 65.13M | 48.01M | 30.76M | 25.92M | 20.84M | 19.90M | 14.58M | 13.73M | 8.01M | 100.50M | 120.98M | 99.73M | 105.03M | 129.67M | 119.13M | 85.25M | 103.14M | 51.76M | 57.01M | 52.90M | -7.60M | -10.50M | -8.20M | -7.10M | -1.60M |
| Cost & Expenses | 143.36M | 135.03M | 165.33M | 108.88M | 98.07M | 85.37M | 80.84M | 70.77M | 65.13M | 48.01M | 30.76M | 25.92M | 20.84M | 19.90M | 14.58M | 13.73M | 8.01M | 100.50M | 120.98M | 99.73M | 105.03M | 129.67M | 119.13M | 85.25M | 103.14M | 51.76M | 57.01M | 52.90M | -7.60M | -10.50M | -8.20M | -7.10M | -1.60M |
| Interest Income | -2.65M | 44.92M | 50.81M | 52.88M | 56.30M | 0.00 | 18.00K | 0.00 | 0.00 | 0.00 | 6.74M | 1.24M | 6.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Interest Expense | 55.51M | 44.92M | 50.81M | 52.88M | 56.30M | 49.06M | 43.11M | 9.23M | 3.49M | 3.85M | 1.55M | 85.00K | 308.00K | 4.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Depreciation & Amortization | 69.97M | 140.03M | 165.45M | 106.65M | 99.16M | 89.79M | 79.96M | 86.12M | 53.16M | 40.69M | 20.10M | 16.58M | 11.99M | 10.99M | 8.62M | 7.94M | 11.73M | 11.81M | 12.60M | 14.45M | 15.38M | 16.38M | 14.66M | 14.17M | 11.49M | 8.96M | 8.04M | 6.83M | 6.10M | 5.30M | 5.20M | 4.70M | 1.20M |
| EBITDA | 251.49M | 151.99M | 212.99M | 303.95M | 296.83M | 280.59M | 264.99M | 236.08M | 179.36M | 167.06M | 107.63M | 87.66M | 76.05M | 68.15M | 57.57M | 53.34M | 82.87M | 66.31M | 49.38M | 55.29M | 72.84M | 247.76M | 233.19M | 77.60M | 91.44M | 60.18M | 61.21M | 54.48M | 101.60M | 87.20M | 62.90M | 51.20M | 10.70M |
| EBITDA Ratio | 78.63% | 54.64% | 71.30% | 91.33% | 93.32% | 95.24% | 95.09% | 95.00% | 94.00% | 93.17% | 91.23% | 90.42% | 71.48% | 82.01% | 81.52% | 80.51% | 84.55% | 32.83% | 20.37% | 37.71% | 44.83% | 31.39% | 25.71% | 52.61% | 30.69% | 58.83% | 55.55% | 54.79% | 115.59% | 122.13% | 127.07% | 129.95% | 135.44% |
| Operating Income | 178.79M | 81.11M | 132.19M | 220.80M | 220.01M | 209.24M | 197.82M | 177.73M | 163.86M | 106.19M | 77.84M | 71.04M | 61.86M | 58.50M | 49.64M | 49.27M | 54.30M | 50.23M | 36.40M | 55.83M | 57.46M | 42.11M | 20.04M | 62.26M | 28.02M | 50.53M | 53.17M | 46.53M | 95.50M | 81.90M | 57.70M | 46.50M | 9.50M |
| Operating Income Ratio | 55.90% | 29.16% | 44.25% | 66.34% | 69.17% | 71.02% | 70.99% | 71.52% | 71.56% | 59.82% | 66.07% | 73.27% | 74.80% | 74.62% | 77.30% | 78.20% | 87.14% | 33.32% | 23.13% | 35.89% | 35.36% | 24.51% | 14.40% | 42.21% | 21.37% | 49.40% | 48.26% | 46.80% | 108.65% | 114.71% | 116.57% | 118.02% | 120.25% |
| Total Other Income/Expenses | -44.41M | -80.22M | -15.04M | -33.54M | -59.56M | -49.94M | -38.45M | -74.13M | -66.10M | -26.44M | -28.49M | 0.00 | 7.95M | -707.00K | 0.00 | 0.00 | -3.48M | 8.44M | 16.93M | -4.89M | 0.00 | -185.02M | -218.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 134.38M | 65.50M | 111.97M | 185.31M | 160.45M | 154.33M | 159.37M | 153.47M | 149.61M | 103.05M | 79.50M | 74.66M | 81.13M | 69.42M | 64.23M | 57.51M | 67.64M | 62.95M | 53.71M | 67.52M | 0.00 | 47.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 42.02% | 23.55% | 37.48% | 55.68% | 50.44% | 52.39% | 57.19% | 61.76% | 65.33% | 58.05% | 67.47% | 77.01% | 98.10% | 88.55% | 100.01% | 91.28% | 108.55% | 41.76% | 34.13% | 43.41% | 0.00% | 27.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 42.44M | 49.78M | 49.94M | 56.29M | -9.17M | 46.32M | 749.00K | -707.00K | 24.67M | -17.13M | -12.53M | -19.27M | -10.92M | -14.59M | -8.24M | -42.13M | -18.83M | -17.65M | -472.00K | 13.66M | 11.83M | 21.19M | 29.70M | -24.85M | -18.42M | -22.22M | -19.52M | 45.80M | 43.00M | 33.30M | 33.20M | 7.40M |
| Net Income | 135.65M | 23.06M | 62.19M | 135.37M | 104.16M | 154.33M | 159.37M | 151.54M | 148.86M | 101.61M | 106.18M | 90.73M | 81.13M | 69.42M | 64.23M | 57.51M | 96.44M | 69.23M | 54.41M | 56.38M | 43.81M | 30.79M | -63.00K | 33.72M | 53.62M | 69.65M | 75.39M | 67.16M | 49.70M | 38.90M | 24.40M | 13.30M | 2.10M |
| Net Income Ratio | 42.41% | 8.29% | 20.82% | 40.67% | 32.75% | 52.39% | 57.19% | 60.98% | 65.01% | 57.24% | 90.12% | 93.58% | 98.10% | 88.55% | 100.01% | 91.28% | 154.76% | 45.93% | 34.57% | 36.24% | 26.96% | 17.92% | -0.05% | 22.86% | 40.88% | 68.08% | 68.42% | 67.55% | 56.54% | 54.48% | 49.29% | 33.76% | 26.58% |
| EPS | 3.13 | 0.52 | 1.36 | 3.03 | 2.40 | 3.68 | 3.90 | 3.88 | 3.96 | 3.04 | 3.74 | 3.26 | 2.93 | 2.51 | 2.33 | 2.08 | 3.48 | 2.50 | 1.96 | 2.05 | 1.58 | 1.10 | 0.00 | 1.31 | 2.13 | 2.72 | 3.01 | 2.92 | 2.63 | 2.35 | 1.95 | 1.60 | 0.29 |
| EPS Diluted | 3.13 | 0.51 | 1.36 | 3.03 | 2.38 | 3.67 | 3.87 | 3.87 | 3.95 | 3.04 | 3.74 | 3.26 | 2.92 | 2.50 | 2.32 | 2.07 | 3.47 | 2.49 | 1.96 | 2.03 | 1.57 | 1.10 | 0.00 | 1.31 | 2.13 | 2.69 | 2.92 | 2.80 | 2.49 | 2.28 | 1.95 | 1.60 | 0.29 |
| Weighted Avg Shares Out | 43.39M | 44.77M | 45.71M | 44.70M | 43.42M | 41.94M | 40.89M | 39.01M | 37.60M | 33.38M | 28.36M | 27.81M | 27.72M | 27.66M | 27.59M | 27.71M | 27.70M | 27.74M | 27.70M | 27.26M | 26.73M | 26.45M | 24.47M | 24.38M | 24.37M | 24.96M | 24.42M | 21.94M | 16.39M | 13.28M | 12.51M | 7.48M | 7.24M |
| Weighted Avg Shares Out (Dil) | 43.39M | 44.79M | 45.73M | 44.70M | 43.70M | 42.09M | 41.15M | 39.16M | 37.64M | 33.42M | 28.40M | 27.84M | 27.79M | 27.73M | 27.62M | 27.73M | 27.78M | 27.78M | 27.83M | 27.53M | 26.99M | 26.85M | 24.47M | 24.56M | 24.37M | 28.69M | 25.17M | 27.24M | 17.31M | 13.68M | 12.51M | 7.48M | 7.24M |
National Health: Strong Returns Carry REIT Into The Sell Zone
NHI performed well during COVID-19, with a lower FFO loss and steady debt-to-EBITDA ratio compared to peers. Rent coverage for senior housing and skilled nursing facilities has improved, with positive trends in occupancy and NOI margin. The recent rally has...
NHI Announces Second Quarter 2024 Earnings Release and Conference Call Date
MURFREESBORO, TN / ACCESSWIRE / July 15, 2024 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the second quarter ended June 30, 2024. NHI plans to issue its earnings release after the market...
National Health Investors (NHI) Is Up 3.44% in One Week: What You Should Know
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why National Health Investors (NHI) is a Great Choice
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Picking A Winner In Healthcare REITs
Healthcare REITs performed well during the recent earnings season. The sector showed strength and resilience in the face of economic challenges, and enjoys strong tailwinds from the aging of the U.S. population. This article examines growth, balance sheet, dividend, and...
National Health Investors: The Lack Of Upside Seems Obvious To Me Here
National Health Investors is a solid REIT with a BBB- rating and a yield of 5.5%. The company has improved significantly in recent years, but its valuation is no longer attractive for conservative investors.
NHI Files Supplemental Proxy
MURFREESBORO, TN / ACCESSWIRE / May 7, 2024 / National Health Investors, Inc. (NYSE:NHI) filed a proxy statement supplement (the "Supplement") with the U.S. Securities and Exchange Commission ("SEC") on May 6, 2024, which can be found on the SEC...
National Health Investors (NHI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall...
NHI Announces Second Quarter 2024 Dividend
MURFREESBORO, TN / ACCESSWIRE / May 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its second quarter dividend of $0.90 per common share on August 2, 2024 to stockholders of record as of June...
NHI Issues Investor Update
MURFREESBORO, TN / ACCESSWIRE / May 6, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI)...
Source: https://incomestatements.info
Category: Stock Reports